Related Experiment Video
Updated: Jul 4, 2026

04:42
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Change in metabolic parameters in bipolar disorder: A retrospective-to-current evaluation design
Gopika Jagota1, Aseem Mehra1, Swapnajeet Sahoo1
1Department of Psychiatry, Post Graduate Institute of Medical Education and Research Chandigarh, India.
Indian Journal of Psychiatry
|July 3, 2026
Summary
Metabolic syndrome prevalence significantly increased in bipolar disorder patients over four years. This highlights the need for careful monitoring of metabolic health in this population.
Area of Science:
- Psychiatry
- Endocrinology
- Public Health
Background:
- Limited longitudinal data exists on metabolic disturbances in bipolar disorder (BD).
- Metabolic syndrome (MetS) is a growing concern in mental health populations.
- Understanding metabolic changes in BD is crucial for comprehensive patient care.
Purpose of the Study:
- To compare the prevalence of metabolic markers in bipolar disorder patients at two distinct time points.
- To assess the longitudinal changes in metabolic health within a cohort of BD patients.
- To identify trends in metabolic syndrome development in individuals with bipolar disorder.
Main Methods:
- Retrospective-to-current evaluation design with two assessment time points.
- Seventy-four BD patients assessed at baseline and approximately 4 years later.
- International Diabetes Federation's Consensus Criteria used for metabolic syndrome assessment.
Main Results:
- Metabolic syndrome prevalence increased from 37.8% at baseline to 63.5% at follow-up.
- Significant increases observed in weight, BMI, waist circumference, fasting blood glucose, HbA1C, triglycerides, and VLDL.
- Annual incidence rates: Diabetes mellitus (2.42%), hypertension (5.05%), and dyslipidemia (4%).
Conclusions:
- A notable increase in metabolic parameters and MetS prevalence occurred over the 4-year follow-up period.
- These findings underscore the importance of vigilant metabolic monitoring in BD patients.
- Consideration of metabolic health is essential when selecting pharmacotherapies for bipolar disorder.
Related Concept Videos
Bipolar Disorder
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...